Cargando…
Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype.
Characterisation of altered glycosylation of P-glycoprotein (P-gp) found associated with the absence of a multidrug resistance (MDR) phenotype in cell lines prompted an investigation to assess the role of post-translational processing in establishing P-gp efflux pump functionally. The clone A cell l...
Autores principales: | Kramer, R., Weber, T. K., Arceci, R., Ramchurren, N., Kastrinakis, W. V., Steele, G., Summerhayes, I. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033717/ https://www.ncbi.nlm.nih.gov/pubmed/7710927 |
Ejemplares similares
-
Constitutive expression of multidrug resistance in human colorectal tumours and cell lines.
por: Kramer, R., et al.
Publicado: (1993) -
Tunicamycin resistant glycosylation of a coronavirus glycoprotein: Demonstration of a novel type of viral glycoprotein
por: Holmes, Kathryn V., et al.
Publicado: (1981) -
Structure-Based Insight on the Mechanism of N-Glycosylation Inhibition by Tunicamycin
por: Yoon, Danbi, et al.
Publicado: (2023) -
Inhibition of N-linked Glycosylation by Tunicamycin May Contribute to The Treatment of SARS-CoV-2
por: Dawood, Ali Adel, et al.
Publicado: (2020) -
Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation
por: Wu, Jian, et al.
Publicado: (2018)